St. Croix Regional Medical Center was one of the few medical centers in the area that offered monoclonal antibodies treatment for COVID-19. The FDA authorized the use of monoclonal antibodies that are given by IV infusion. These antibodies can attach to parts of the coronavirus and can help the immune system recognize and respond more effectively to the virus.
Once this treatment was authorized, St. Croix Regional Medical Center quickly gathered a team together to develop the process and ensure we had the necessary supplies to help its patients. Within weeks they had created a separate, negative air-controlled space to deliver this necessary treatment to patients who qualified.